Ethicon Receives 510(k) Clearance for ENSEAL® G2 Articulating
To address surgeons need for strong sealing in tight spaces where
access is limited, Ethicon Endo-Surgery, Inc. (Ethicon) today announces
the 510(k) clearance from the U.S. Food and Drug Administration for the
ENSEAL G2 Articulating Tissue Sealer. ENSEAL
G2 Articulating is the first articulating advanced energy device
designed to allow surgeons to take a perpendicular approach to seal
vessels up to 7mm in diameter and lymphatics through a 5mm port. Vessels
sealed perpendicularly are stronger than those sealed at oblique
angles.* Stronger sealing helps reduce the likelihood of internal
bleeding and post-surgery complications.
One of the big challenges surgeons face when performing colorectal,
gynecological and general surgeries is operating in challenging anatomy.
ENSEALG2 Articulating will help surgeons maneuver
around corners and behind structures in the body, and provide better
access to tissue in deep or tight spaces for greater control of the
angle of approach to vessels.
The articulation helps give me a perpendicular angle on vessels which
gives me a strong seal in one bite, says Steven A. Elg, M.D., GYN
Oncologist, Iowa Methodist. For my oncology patients, I anticipate that
it will help in the tight spots where access is limited and making
ENSEAL G2 Articulating builds on the unique benefits of the
ENSEAL portfolio, which is designed for superior tissue
sealing by providing uniform compression, controlling temperature and
minimizing thermal spread. The Proprietary I-BLADE
technology delivers high uniform compression for sealing vessels
consistently along the length of the jaw. The proprietary offset
electrode configuration device is designed to minimize thermal spread.
Other bipolar devices do not have the Positive Temperature Coefficient
technology and offset electrode configuration designed for minimizing
energy spread into surrounding tissue.
ENSEAL G2 Articulating builds on an existing portfolio of
advanced bipolar tissue sealers designed to give surgeons confidence and
choice in surgery, said Dr. Joe Amaral, Ethicon Chief Scientific
Officer. Ethicon continues to work with surgeons around the world and
across specialties to design innovations to help surgeons deliver the
best outcomes based on the unique needs of their patients and
Ethicon is a leader in advanced energy solutions and offers the broadest
portfolio of ultrasonic energy devices using HARMONICtechnology
and advanced bipolar energy devices using ENSEAL technology. Click
here to learn more.
HARMONIC ultrasonic devices combine precision and
multifunctionality: With a jaw and blade uniquely designed for precise
dissection, sealing and transection, one device enables surgeons to
perform multiple jobs without instrument exchanges. HARMONICis
used in more than 14 million surgical procedures annually around the
here to learn more.
ENSEALadvanced bipolar devices are strong on sealing, yet
gentle on tissue. With an I-BLADEthat delivers high uniform
compression along the entire length of the jaw, ENSEAL® seals vessels up
to 7mm diameter. The G2 line also includes the ENSEAL G2
Super Jaw device, launched in 2011, and the ENSEAL® G2 Curved and
Straight Tissue Sealers, launched in 2012. Click
here to learn more.
The ETHICON brand is used for the products of Ethicon, Inc. and Ethicon
Endo-Surgery, Inc., two companies with long histories of medical
innovation, which provide globally a broad range of surgical
technologies and products (including energy devices, sutures, staplers,
clip appliers, trocars and meshes) used to treat colorectal and thoracic
conditions, womens health conditions, hernias, cancer and obesity.
Ethicon, Inc. and Ethicon Endo-Surgery, Inc. are part of the Johnson &
Johnson Family of Companies. www.ethicon.com
Dr. Steven A. Elg is a paid consultant for Ethicon Endo-Surgery.
*Compared to a non-articulating device. Based on a benchtop burst
pressure study number PRC051608.
Ethicon Endo-Surgery, Inc.Bridgett Golden, firstname.lastname@example.orgAnn
Source: Ethicon Endo-Surgery, Inc.